Photo by Vasant Jain on Unsplash
Thailand’s medical device sector continues to gain importance for OTC, self‑medication, and Rx companies targeting the broader Asian market. Demand is expanding across diagnostics, hospital technologies, and home‑care monitoring, while streamlined regulations enhance predictability for market entry.
Why Thailand Matters for MedTech Expansion
The Thailand medical device market is projected to expand from approximately USD 4.03 billion by 2030 to nearly USD 8.5 billion by 2040, reflecting an estimated CAGR of around 7.70%.
Endoscopic devices alone are expected to surpass USD 240 million by 2030, reflecting hospital investments in MedTech minimally invasive care. Design, development, and contract manufacturing services are also increasing, indicating a more mature and innovation‑driven ecosystem.
These segments present strong opportunities for device innovators and OTC/Rx players with adjacent technology portfolios, especially in diagnostics, smart monitoring, and preventive care.
Thai FDA: The Central Regulatory Authority
The Thai Food and Drug Administration (Thai FDA), under the Ministry of Public Health, is responsible for ensuring safety, quality, and efficacy of medical devices.
Regulatory oversight specifically lies with the Medical Device Control Division (MDCD). This makes early regulatory planning essential for market entry, especially for foreign OTC & Rx players that require compliant documentation, local representation, and licensing.
Thailand Medical Device Registration Process
Once the Establishment License is obtained, a mandatory prerequisite for both manufacturers and importers, the product‑specific registration process can begin.
The first step is to classify the device according to Thailand’s risk‑based system, which determines whether it must be Listed, Notified, or Licensed as shown below:
- Class I (Low‑Risk): Class I devices are considered low‑risk and follow the Listed pathway with minimal documentation requirements.
- Class II & some Class III (Moderate Risk): These devices fall under the Notified category, requiring a higher evidence package than Listed products.
- Class III & Class IV (High‑Risk): These products require Licensing, the most rigorous Thai FDA pathway.
Figure 1: Thailand Medical Device Regulatory Approval Process
Important Considerations in Thailand for MDs from EU and the USA
Beyond classification and registration, two regulatory levers can significantly influence successful MedTech market entry in Thailand. Strict Thai-language labeling requirements are frequently underestimated and can delay approval if not aligned early in the regulatory strategy.
In addition, devices already approved in the EU (CE mark) or US (FDA clearance/approval) may benefit from accelerated Thai FDA review under reliance principles, potentially reducing time-to-market for globally active OTC & Rx companies.
Structuring documentation correctly and leveraging these regulatory advantages requires early strategic planning, an area where Chameleon Pharma Consulting supports companies through regulatory alignment, market entry preparation, and systematic local partner company identification to ensure both compliance and commercial success in Asia.
Chameleon Pharma Consulting Group (CPC) has over 20 years of experience in supporting Pharma, OTC, Medical Devices, Phyto, and Aesthetic Medicine companies. Having established own offices & local hubs across Latin America, Europe, Asia, the US/Canada, the Middle East, and the CEE/CIS regions is another advantage of CPC. With this local network and expertise gained from 300+ international projects and a team of 25 experts we offer our clients:
- Business Development, M&A, and Due Diligence
- Market Entry & Expansion: Systematic product and country analysis, market reports
- Strategic Partnering: Identifying local partners, acquisitions, or setting up own offices
- Regulatory & Registration: for drugs, MD, Derma, Aesthetic Medicine, etc.
- Market Authorization & Compliance: Holding MAs, conducting pharmacovigilance
- Quality & Certification: GMP certification, pre-GMP audits
Contact us today for your individual request at service@chameleon-pharma.com!
